VE-821
SIGMA/SML1415 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 1232410-49-9
Empirical Formula (Hill Notation): C18H16N4O3S
Molecular Weight: 368.41
MDL Number: MFCD19443686
Linear Formula: C18H16N4O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H16N4O3S/c1-26(24,2 |
| InChI key | DUIHHZKTCSNTGM-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CS(C(C=C1)=CC=C1C2=NC(C(N |
| solubility | DMSO: ≥10 mg/mL, clear |
| storage temp. | −20°C |
| Application: | VE-821 has been used as an inhibitor of ATM- and Rad3-related (ATR) protein in human cancer cells. |
| Biochem/physiol Actions: | VE-821 is a ATP-competitive inhibitor of ATR. |
| Biochem/physiol Actions: | VE-821 is a potent ATP-competitive inhibitor of the DNA damage response (DDR) kinase Ataxia telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) with a Ki of 13 nM. VE-821 has minimal cross-reactivity against the related PIKKs ATM, DNA-dependent protein kinase (DNA-PK), mTOR and PI3-kinase-γ (Ki of 16 μM, 2.2 μM, >1 μM and 3.9 μM, respectively) and against a large panel of unrelated protein kinases. VE-821 used alone caused death in a large fraction of cancer cell populations and also showed strong synergy with genotoxic agents. VE-821 increased sensitivity of cells to radiation and also sensitized cancer cells to a variety of chemotherapeutic agents. |
| Other Notes: | VE-821 has been expertly reviewed and recommended by the Chemical Probes Portal. For more information, please visit the VE-821 probe summary ![]() |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

